AVANI GOKALDAS: Open Payments
NPI 1417906017 · FOOTHILL RANCH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,254 in 90 payments from 13 companies in 2025. Trend: 2023 $1,810 · 2024 $1,991 · 2025 $2,254
Food & beverage: $2,092Education: $162
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $638 |
| Madrigal Pharmaceuticals | 9 | $368 |
| Ardelyx, Inc. | 14 | $308 |
| GENZYME CORPORATION | 5 | $213 |
| Regeneron Healthcare Solutions, Inc. | 2 | $145 |
| ABBVIE INC. | 9 | $135 |
| Phathom Pharmaceuticals, Inc. | 8 | $134 |
| PFIZER INC. | 5 | $110 |
| Aimmune Therapeutics, Inc. | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
Products named: TREMFYA, REZDIFFRA, IBSRELA, DUPIXENT, VOQUEZNA, XELJANZ, SKYRIZI, RINVOQ.
Industry payments across CA — which companies pay providers there.
